Focused protein degradation is getting explored instead approach in cancer, whereby the pure protein degradation technique is co-opted for therapeutic uses. A short while ago designed novel molecules identified as proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A single ligand binds for the https://www.directivepublications.org/journal-of-clinical-breast-cancer/